Nidogen 1‐Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1

In hepatocellular carcinoma (HCC) patients with extrahepatic metastasis, the lung is the most frequent site of metastasis. However, how the lung microenvironment favors disseminated cells remains unclear. Here, it is found that nidogen 1 (NID1) in metastatic HCC cell‐derived extracellular vesicles (EVs) promotes pre‐metastatic niche formation in the lung by enhancing angiogenesis and pulmonary endothelial permeability to facilitate colonization of tumor cells and extrahepatic metastasis. EV‐NID1 also activates fibroblasts, which secrete tumor necrosis factor receptor 1 (TNFR1), facilitate lung colonization of tumor cells, and augment HCC cell growth and motility. Administration of anti‐TNFR1 antibody effectively diminishes lung metastasis induced by the metastatic HCC cell‐derived EVs in mice. In the clinical perspective, analysis of serum EV‐NID1 and TNFR1 in HCC patients reveals their positive correlation and association with tumor stages suggesting the potential of these molecules as noninvasive biomarkers for the early detection of HCC. In conclusion, these results demonstrate the interplay of HCC EVs and activated fibroblasts in pre‐metastatic niche formation and how blockage of their functions inhibits distant metastasis to the lungs. This study offers promise for the new direction of HCC treatment by targeting oncogenic EV components and their mediated pathways.

[1]  Kai-Ping Chang,et al.  Proteomic Profiling of Paired Interstitial Fluids Reveals Dysregulated Pathways and Salivary NID1 as a Biomarker of Oral Cavity Squamous Cell Carcinoma* , 2019, Molecular & Cellular Proteomics.

[2]  F. Wang,et al.  Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR‐23a‐3p and Up‐regulate Programmed Death Ligand 1 Expression in Macrophages , 2019, Hepatology.

[3]  E. Dejana,et al.  Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells , 2019, BMC Cancer.

[4]  C. Brakebusch,et al.  Cancer-associated fibroblasts: how do they contribute to metastasis? , 2019, Clinical & Experimental Metastasis.

[5]  S. Xiao,et al.  miR‐125a/b inhibits tumor‐associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90 , 2018, Journal of cellular biochemistry.

[6]  Martin Eisenacher,et al.  The PRIDE database and related tools and resources in 2019: improving support for quantification data , 2018, Nucleic Acids Res..

[7]  N. Socci,et al.  Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers. , 2018, Cancer research.

[8]  Shi‐Mei Zhuang,et al.  Hepatoma cell‐secreted exosomal microRNA‐103 increases vascular permeability and promotes metastasis by targeting junction proteins , 2018, Hepatology.

[9]  G. Mælandsmo,et al.  Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease , 2018, BMC Cancer.

[10]  M. Ferrer,et al.  High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer , 2018, Scientific Reports.

[11]  X. Bai,et al.  Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility , 2018, Oncogene.

[12]  Piao Guo,et al.  HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway , 2018, Cell Death & Disease.

[13]  Inna Kuperstein,et al.  Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer. , 2018, Cancer cell.

[14]  K. Nan,et al.  Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway , 2018, Journal of experimental & clinical cancer research : CR.

[15]  Xiao-jing Yang,et al.  Hepatocellular Carcinoma Cell-Secreted Exosomal MicroRNA-210 Promotes Angiogenesis In Vitro and In Vivo , 2018, Molecular therapy. Nucleic acids.

[16]  Hongyang Wang,et al.  Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer , 2018, Nature Communications.

[17]  P. Rochaix,et al.  TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma , 2017, Nature Communications.

[18]  G. Chen,et al.  New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies. , 2017, Biochimica et biophysica acta. Reviews on cancer.

[19]  E. King,et al.  Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4 , 2017, Journal of the National Cancer Institute.

[20]  B. Garcia,et al.  Identification of Nidogen 1 as a lung metastasis protein through secretome analysis , 2017, Genes & development.

[21]  Qing‐Yu He,et al.  Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes , 2017, Proteomics.

[22]  Thomas R. Cox,et al.  Pre-metastatic niches: organ-specific homes for metastases , 2017, Nature Reviews Cancer.

[23]  Yitao Wang,et al.  NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells , 2017, Oncotarget.

[24]  A. Nowacki,et al.  Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma , 2017, Journal of Neuro-Oncology.

[25]  I. Ng,et al.  Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling. , 2016, Cell reports.

[26]  S. Tsao,et al.  Proteomic analysis of exosomes from nasopharyngeal carcinoma cell identifies intercellular transfer of angiogenic proteins , 2015, International journal of cancer.

[27]  P. Lichter,et al.  Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. , 2015, Blood.

[28]  X. Wang,et al.  Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma , 2015, Hepatology.

[29]  N. Wong,et al.  Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs. , 2015, Carcinogenesis.

[30]  C. Shun,et al.  Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis. , 2015, Cancer research.

[31]  B. Storer,et al.  Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment. , 2015, Blood.

[32]  L. Larue,et al.  Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines , 2015, Pigment cell & melanoma research.

[33]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[34]  Marta García,et al.  Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion , 2015, Clinical & Experimental Metastasis.

[35]  E. Ingelsson,et al.  Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes - findings from two community based cohorts of elderly. , 2014, Atherosclerosis.

[36]  M. Karin,et al.  ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. , 2014, Cancer cell.

[37]  A. Duseja.  Staging of hepatocellular carcinoma. , 2014, Journal of clinical and experimental hepatology.

[38]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[39]  F. Shen,et al.  Association of tumor-associated fibroblasts with progression of hepatocellular carcinoma , 2013, Medical Oncology.

[40]  P. Carmeliet,et al.  Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium. , 2013, The Journal of clinical investigation.

[41]  C. Blobel,et al.  Stromal fibroblast-specific expression of ADAM-9 modulates proliferation and apoptosis in melanoma cells in vitro and in vivo. , 2012, The Journal of investigative dermatology.

[42]  Kaitai Zhang,et al.  The ovarian cancer‐derived secretory/releasing proteome: A repertoire of tumor markers , 2012, Proteomics.

[43]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[44]  Michael Wigler,et al.  A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions , 2012, Proceedings of the National Academy of Sciences.

[45]  J. Chang-Claude,et al.  Tumor necrosis factor (TNF)‐α, soluble TNF receptors and endometrial cancer risk: The EPIC study , 2011, International journal of cancer.

[46]  Wen-Lang Lin,et al.  Intercellular nanovesicle‐mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth , 2011, Hepatology.

[47]  Raghu Kalluri,et al.  VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization , 2011, Proceedings of the National Academy of Sciences.

[48]  D. Coppola,et al.  Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice , 2011, Clinical Cancer Research.

[49]  James O. Jones,et al.  Suppression of Antitumor Immunity by Stromal Cells Expressing , 2022 .

[50]  K. Horiuchi,et al.  Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice. , 2010, The Journal of clinical investigation.

[51]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[52]  G. Giannelli,et al.  Down‐regulation of connective tissue growth factor by inhibition of transforming growth factor β blocks the tumor–stroma cross‐talk and tumor progression in hepatocellular carcinoma , 2010, Hepatology.

[53]  Hubing Shi,et al.  Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis. , 2009, Cancer research.

[54]  Trairak Pisitkun,et al.  Large-scale proteomics and phosphoproteomics of urinary exosomes. , 2009, Journal of the American Society of Nephrology : JASN.

[55]  Johan Skog,et al.  Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.

[56]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[57]  Y. Li,et al.  Role of ADAM17 in the ectodomain shedding of TNF‐α and its receptors by neutrophils and macrophages , 2007, Journal of leukocyte biology.

[58]  M. Kaler,et al.  Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Roy-Chowdhury,et al.  A long‐term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag‐2–deficient mice , 2000, Hepatology.

[60]  Zeng-chen Ma,et al.  Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues , 1996, International journal of cancer.

[61]  Chao Wu,et al.  Exosomal miR-451a Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting LPIN1. , 2019, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

[62]  D. Xie,et al.  Establishment of cell lines from a primary hepatocellular carcinoma and its metastatis. , 2004, Cancer genetics and cytogenetics.